These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 31965968)
21. Botulinum toxins in the treatment of primary focal dystonias. Truong D J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699 [TBL] [Abstract][Full Text] [Related]
22. Stereotactic Lesioning of the Thalamic Vo Nucleus for the Treatment of Writer's Cramp (Focal Hand Dystonia). Shimizu T; Maruo T; Miura S; Kishima H; Ushio Y; Goto S Front Neurol; 2018; 9():1008. PubMed ID: 30534112 [TBL] [Abstract][Full Text] [Related]
29. Treatment of upper limb dystonia with botulinum toxin. Hayes MW; Yiannikas C J Clin Neurosci; 1996 Apr; 3(2):124-8. PubMed ID: 18638853 [TBL] [Abstract][Full Text] [Related]
30. Primary Writing Tremor. Vives-Rodriguez A; Kim CY; Louis ED Tremor Other Hyperkinet Mov (N Y); 2018; 8():586. PubMed ID: 30402337 [TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin in clinical practice. Hughes AJ Drugs; 1994 Dec; 48(6):888-93. PubMed ID: 7533696 [TBL] [Abstract][Full Text] [Related]
32. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Pullman SL; Greene P; Fahn S; Pedersen SF Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169 [TBL] [Abstract][Full Text] [Related]
33. Writer's cramp: the experience with botulinum toxin injections in 25 patients. Poungvarin N J Med Assoc Thai; 1991 May; 74(5):239-47. PubMed ID: 1783871 [TBL] [Abstract][Full Text] [Related]
34. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System. Yoshida K Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448891 [TBL] [Abstract][Full Text] [Related]
35. Update on the Use of Botulinum Toxin Therapy for Focal and Task-Specific Dystonias. Lungu C; Ahmad OF Semin Neurol; 2016 Feb; 36(1):41-6. PubMed ID: 26866495 [TBL] [Abstract][Full Text] [Related]
36. Botulinum toxins: pharmacology and its current therapeutic evidence for use. Panicker JN; Muthane UB Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921 [TBL] [Abstract][Full Text] [Related]
38. Double-blind trial of botulinum toxin for treatment of focal hand dystonia. Cole R; Hallett M; Cohen LG Mov Disord; 1995 Jul; 10(4):466-71. PubMed ID: 7565828 [TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group. Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632 [TBL] [Abstract][Full Text] [Related]
40. Focal task specific dystonia: a review and update. Stahl CM; Frucht SJ J Neurol; 2017 Jul; 264(7):1536-1541. PubMed ID: 28039522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]